NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.

BOSTON, Nov. 6, 2023 -- (Healthcare Sales & Marketing Network) -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appointment of James P. Tursi, M.D... Biopharmaceuticals, Personnel NeuroBo Pharmaceuticals, Non-Alcoholic Steatohepatitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news